Replies to post #1271 on GTC Biotherapeutics (fka GTCB)

[y3maxx]

Tino and Spice...

""european entities have been aquiring peices of gtcb""

seems more obvious now doesn't it.

"4. $17.5M remains on GTC’s shelf registration. However, CFO Jack Green stated on today’s CC that cash usage during 2007 is expected to be similar to cash usage in 2006, and hence GTC believes there is ample cash to last into 2008" (empathesis is yours)

I've posted this before too...

Question,,, is the GTCB CFO really receiving 100K shares for structuring the LFB deal? If so, there's your "shareholder sellout". If true, Dew, even you would admit the LFB isn't kosher.

CEO Cox has a "British accent" doesn't he? hmmmm

Bottom line is, the CEO and CFO are steering GTCB business and ownership to the Europeans because thats who are the players in transgenics. The U.S.FDA is 3 or 5 years behind in support and the American current mindset is "transgenics equals cloning."

IMO, its okay to even do 100% business with the Europeans, they're the players, but losing ownership control to them would only benefit Cox with a Nobel prize, CEO Green with millions in his pocket and legacy common getting screwed.

jmo